Thermo Fisher Scientific Inc has launched the first test kits to enable serological detection of the Zika virus in research applications in the US. The kits, manufactured by Euroimmun AG, can differentiate between Zika, dengue and chikungunya viruses. These tests also enable researchers to detect the virus in samples over a much longer period of time than is possible with current direct-detection assays.
The Euroimmun Anti-Zika Virus ELISA and indirect immunofluorescence (IFA) test formats allow researchers to detect specific antibodies (IgM and IgG) in blood samples. The highly specific viral antigen used in the assays virtually eliminates cross reactivity with other flavivirus antibodies that are known to interact with the Zika virus, enabling reliable differentiation from viruses such as dengue fever. The Euroimmun antibody detection test kits can be run on fully automated analyzers, allowing researchers to work with large volumes of samples to better understand the virus.
“Since first learning about the Zika outbreak, we have worked closely with our colleagues at Euroimmun to mobilise resources and address this urgent need. The Euroimmun test kits are an important step forward in the ongoing Zika response by facilitating a better understanding of the virus,” said Mark Zacur, vice president and general manager of Thermo Fisher’s healthcare market channel.
Euroimmun AG, headquartered in Luebeck (Germany), is an international manufacturer of laboratory reagents and instrument systems for autoimmune diseases, infectious diseases, allergies and gene analytics.
The Euroimmun Anti-Zika Virus ELISA and indirect immunofluorescence (IFA) test formats allow researchers to detect specific antibodies (IgM and IgG) in blood samples. The highly specific viral antigen used in the assays virtually eliminates cross reactivity with other flavivirus antibodies that are known to interact with the Zika virus, enabling reliable differentiation from viruses such as dengue fever. The Euroimmun antibody detection test kits can be run on fully automated analyzers, allowing researchers to work with large volumes of samples to better understand the virus.
“Since first learning about the Zika outbreak, we have worked closely with our colleagues at Euroimmun to mobilise resources and address this urgent need. The Euroimmun test kits are an important step forward in the ongoing Zika response by facilitating a better understanding of the virus,” said Mark Zacur, vice president and general manager of Thermo Fisher’s healthcare market channel.
Euroimmun AG, headquartered in Luebeck (Germany), is an international manufacturer of laboratory reagents and instrument systems for autoimmune diseases, infectious diseases, allergies and gene analytics.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%